NurExone Biologic Inc. announced the appointment of Eran Ovadya, the existing chief financial officer of the Company, to also serve as secretary.
NurExone Biologic Inc. Toronto S.E.
Equities
ENER
CA29278Q1063
Biotechnology & Medical Research
1st Jan change | Capi. | |
---|---|---|
+17.96% | 44.96B | |
+48.77% | 41.85B | |
+1.17% | 42.65B | |
-4.27% | 29.04B | |
+11.42% | 26.08B | |
-21.39% | 19.03B | |
+4.86% | 12.75B | |
+27.29% | 12.06B | |
-3.50% | 11.75B |